Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $729.03M.
ENTERPRISE VALUE (EV)
$729.03M
Attovia Therapeutics, Inc.
Market Cap
$767.30M
Enterprise Value (EV)
$729.03M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Attovia Therapeutics, Inc. (ATTO) | $767.30M | $729.03M |
| Mesa Laboratories, Inc. (MLAB)vs › | $764.65M | $835.31M |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $775.12M | $793.48M |
| Sana Biotechnology, Inc. (SANA)vs › | $777.83M | $794.49M |
| Design Therapeutics, Inc. (DSGN)vs › | $754.64M | $743.76M |
| Apnimed, Inc. (APMD)vs › | $785.11M | N/A |
| Geron Corporation (GERN)vs › | $789.07M | $848.57M |
| Gyre Therapeutics, Inc. (GYRE)vs › | $791.07M | $751.20M |
| AdaptHealth Corp. (AHCO)vs › | $796.57M | $2.82B |
| Faeth Therapeutics, Inc. (FTH)vs › | $735.87M | $709.56M |
Market Cap
$767.30M
Total Debt
$1.92M
Cash
$40.19M
Enterprise Value
$729.03M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
